RPRX — ROYALTY PHARMA PLC

Ownership history in MATHER GROUP, LLC.  ·  5 quarters on record

This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in ROYALTY PHARMA PLC (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 8 -72 -90.0% 0.00% $290 $34.90
2025 Q1 REDUCED 80 -27 -25.2% 0.00% $2K $30.41
2024 Q3 ADDED 107 +91 +568.8% 0.00% $3K $27.23
2024 Q2 REDUCED 16 -10 -38.5% 0.00% $494 $25.18
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RPRX price (monthly, adj. close)

Other funds also holding RPRX

As of 2025 Q4 — sorted by position size

Dorsey Asset Management, LLC 3Y 7Y 7.59% Regal Partners Ltd 3Y 7Y 5.88% Caledonia (Private) Investments Pty Ltd 3Y 7Y 5.46% NEW SOUTH CAPITAL MANAGEMENT INC 3Y 7Y 5.21% Patient Capital Management, LLC 3Y 4.97% Lion Point Capital, LP 3Y 7Y 4.28% TORRAY INVESTMENT PARTNERS LLC 3Y 7Y 4.12% Goodman Advisory Group, LLC 3Y 2.67% CM Management, LLC 3Y 2.44% Inlet Private Wealth, LLC 3Y 7Y 2.02%
← Back to MATHER GROUP, LLC. Holdings